NEXTURN&ROLLKOREA Co., Ltd
Financials
Valuation Metrics
NEXTURN&ROLLKOREA Co., Ltd's Market Cap is ₩316B. At end of 2025 it was ₩333B. Ranked #2052 of 2,421 in KR market (top 85%), #1311 of 1,640 on KOSDAQ (top 80%), #324 of 361 in Capital Goods (top 90%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 31.63B KRW | KR#2,052/2,421 Sec#324/361 |
| Revenue | 112.61B KRW | KR#1,349/2,421 Sec#222/361 |
| Net Income | 1.61B KRW | KR#1,440/2,421 Sec#224/361 |
| Total Assets | 313.67B KRW | KR#1,009/2,421 Sec#174/361 |
| Net Assets | 238.49B KRW | KR#850/2,421 Sec#150/361 |
| Employees | 57 | KR#1,989/2,421 Sec#298/361 |
| Value | ||
| P/E | 19.66x | KR#1,163/2,421 Sec#176/361 |
| P/B | 0.13x | KR#37/2,421 Sec#7/361 |
| PEG | 0.22x | KR#571/2,421 Sec#87/361 |
| P/S | 0.28x | KR#550/2,421 Sec#81/361 |
| EV/EBITDA | 3.40x | KR#105/2,421 Sec#12/361 |
| FCF Yield | -18.99% | KR—/2,421 Sec—/361 |
| Profitability | ||
| ROE | 0.67% | KR#1,505/2,421 Sec#232/361 |
| ROA | 0.51% | KR#1,478/2,421 Sec#229/361 |
| Op. Margin | 12.06% | KR#419/2,421 Sec#60/361 |
| Revenue Growth | 197.35% | KR#39/2,421 Sec#4/361 |
| Earnings Growth | 88.72% | KR#420/2,421 Sec#59/361 |
| Financial Health | ||
| Debt Ratio | 31.52% | KR#615/2,421 Sec#70/361 |
| Total Debt | 48.18B KRW | KR#1,018/2,421 Sec#178/361 |
| FCF | -6.01B KRW | KR#1,542/2,421 Sec#230/361 |
| Cash | 33.61B KRW | KR#938/2,421 Sec#163/361 |
| Current Ratio | 2.49x | KR#695/2,421 Sec#78/361 |
| Net Debt/EBITDA | 1.07x | KR#743/2,421 Sec#93/361 |
| Dividend | ||
| Div. Growth | 0.00% | KR—/2,421 Sec—/361 |
| Performance | ||
| 1Y Return | -13.78% | KR#1,076/2,421 Sec#187/361 |
| 1M Return | -12.31% | KR#2,177/2,421 Sec#336/361 |
| From 52W High | -36.46% | KR#770/2,421 Sec#97/361 |
| 1Y MDD | -38.13% | KR#518/2,421 Sec#61/361 |
| Trading | ||
| Volume | 20,548 shares | KR#1,576/2,421 Sec#280/361 |
| Trading Value | 42.8M KRW | KR#1,891/2,421 Sec#315/361 |
| Foreign Own. | 1.38% | KR#1,873/2,421 Sec#287/361 |
| Per Share | ||
| EPS | 105 KRW | KR#1,414/2,421 Sec#224/361 |
| BPS | 15,571 KRW | KR#677/2,421 Sec#116/361 |
Company Info
Established in 2000 for manufacturing and selling CNC automatic lathes, the company changed its name to Nexturn Bioscience in 2021 and was listed on KOSDAQ in 2006. It supplies CNC automatic lathes to diverse industries including automotive, communication equipment, medical parts, and electronic home appliances, and also operates businesses in heavy equipment components and semiconductor equipment. Through in-house technology development, it expanded market share with unmanned automation processing equipment. The company is pursuing entry into the new medical device business after successfully completing a national project to develop a cardiovascular interventional procedure assistance robot. Nexturn & Rol Korea was established in 2000 and is headquartered in Yongin-si, Gyeonggi-do.